$9.050
-0.205 (-2.27%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Agomab Therapeutics NV (AGMB) Moving Averages Convergence Divergence (MACD) indicator is -0.72, suggesting AGMB is Sell.
Agomab Therapeutics NV (AGMB) 20-Day simple moving average is 9.06, while Agomab Therapeutics NV (AGMB) share price is $—, making it Sell.
Agomab Therapeutics NV (AGMB) 60-Day simple moving average is 11.91, while Agomab Therapeutics NV (AGMB) share price is $—, making it Sell.
Technical Analysis for AGMB
AI Technical AGMBAs of 2026-10-17, the technical board for Agomab Therapeutics NV (AGMB) reads sell: 2 indicators are flashing buy, 7 are indicating sell, and 4 are neutral. Price at $9.05 sits below the 20-day, 60-day and 200-day moving averages and above the 5-day and 10-day.
Momentum readings: RSI stands at 41.619, MACD stands at -0.721 (Sell), Stochastic %K stands at 70.52, Stochastic %D stands at 53.691 and CCI stands at -21.626.
AGMB trades below the 60-day SMA (11.91) and below the 200-day SMA (12.24). Immediate resistance sits at Classic R1 9.63, then R2 10.51. Support sits at Classic S1 7.90, then S2 7.05.
Agomab Therapeutics NV (AGMB) Support & Resistance Level
Agomab Therapeutics NV (AGMB) Technical Indicators
2026-10-17
| Name | Value |
|---|---|
| RSI_14 | 41.619 |
| STOCHk_14_3_3 | 70.520 |
| STOCHd_14_3_3 | 53.691 |
| CCI_20 | -21.626 |
| AO_5_34 | -1.763 |
| MOM_10 | -0.030 |
| MACD_12_26_9 | -0.721 |
Agomab Therapeutics NV (AGMB) Relative Strength Index (RSI_14) is 41.619, creating a Neutral signal.
Agomab Therapeutics NV (AGMB) Stochastic %K is 70.520, creating a Neutral signal.
Agomab Therapeutics NV (AGMB) Stochastic %D is 53.691, creating a Neutral signal.
Agomab Therapeutics NV (AGMB) CCI_20 is -21.626, creating a Neutral signal.
Agomab Therapeutics NV (AGMB) Awesome Oscillator (AO) is -1.763, creating a Sell signal.
Agomab Therapeutics NV (AGMB) Momentum (MOM) is -0.030, creating a Sell signal.
Agomab Therapeutics NV (AGMB) Moving Average Convergence Divergence (MACD) is -0.721, creating a Sell signal.
Agomab Therapeutics NV (AGMB) Moving Average
2026-10-17
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 8.876 | Buy |
| MA_10 | 8.758 | Buy |
| MA_20 | 9.063 | Sell |
| MA_60 | 11.913 | Sell |
| MA_200 | 12.238 | Sell |
| MA_250 | 12.238 | Sell |
Agomab Therapeutics NV (AGMB) 5-Day simple moving average is 8.876, while Agomab Therapeutics NV (AGMB) share price is $, making it a Buy.
Agomab Therapeutics NV (AGMB) 10-Day simple moving average is 8.758, while Agomab Therapeutics NV (AGMB) share price is $, making it a Buy.
Agomab Therapeutics NV (AGMB) 20-Day simple moving average is 9.063, while Agomab Therapeutics NV (AGMB) share price is $, making it a Sell.
Agomab Therapeutics NV (AGMB) 60-Day simple moving average is 11.913, while Agomab Therapeutics NV (AGMB) share price is $, making it a Sell.
Agomab Therapeutics NV (AGMB) 200-Day simple moving average is 12.238, while Agomab Therapeutics NV (AGMB) share price is $, making it a Sell.
Agomab Therapeutics NV (AGMB) 250-Day simple moving average is 12.238, while Agomab Therapeutics NV (AGMB) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.